Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 53, 2024 - Issue 3
Submit an article Journal homepage
303
Views
0
CrossRef citations to date
0
Altmetric
Letters

Chronic miliary gout complicated by chronic renal failure: a case report

X ZhangDepartment of Nephrology, The Second Clinical College of Guizhou University of Chinese Medicine, Guiyang, P.R. ChinaORCID Iconhttps://orcid.org/0009-0005-3500-6546View further author information
ORCID Icon,
Z LiDepartment of Nephrology, The Second Clinical College of Guizhou University of Chinese Medicine, Guiyang, P.R. ChinaORCID Iconhttps://orcid.org/0000-0001-9803-8223View further author information
ORCID Icon,
Y ZhouDepartment of Nephrology, The Second Clinical College of Guizhou University of Chinese Medicine, Guiyang, P.R. ChinaORCID Iconhttps://orcid.org/0009-0000-6240-827XView further author information
ORCID Icon &
L HuangDepartment of Nephrology, The Second Clinical College of Guizhou University of Chinese Medicine, Guiyang, P.R. ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0009-0005-1790-8343View further author information
ORCID Icon
Pages 233-235 | Received 14 Jan 2024, Accepted 05 Feb 2024, Published online: 26 Feb 2024

References

  • Peng YL, Tain YL, Lee CT, Yang YH, Huang YB, Wen YH, et al. Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease. Sci Rep 2020;10:10734.
  • Pradhan S, Sinha R, Sharma P, Sinha U. Atypical cutaneous presentation of chronic tophaceous gout: a case report. Indian Dermatol Online J 2020;11:235–8.
  • Jeong HJ, Park WY, Kim SH, Dalbeth N, Son CN. Urate-lowering efficacy and renal safety of febuxostat in patients with hyperuricemia and stage 4-5 chronic kidney disease not yet on dialysis: a meta-analysis of observational studies. Semin Arthritis Rheum 2022;56:152073.
  • Hu AM, Brown JN. Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review. Clin Rheumatol 2020;39:3287–94.
  • Enríquez LA, Soto FC, Carranza EF, Clavijo CD, Lopez RA, Pineda C. Miliarial-type gout in association with chronic use of glucocorticoids. Rheumatol Int 2024;44:543–547.
  • FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care Res (Hoboken) 2020;72:744–60.
  • Wei L, Wee CLP, Lee JSS, Wang DY. Miliarial gout: clinical case and a brief review. Aust J Dermatol 2022;63:95–7.
  • Preston A, Evanson B, Fiala K. Diagnosing an ulcerated gouty tophus. Baylor Univ Med Center Proc 2019;32:96–8.
  • Théau C, Pauline B, Emilie C, Pascal G, François R. From skin to microscope, case report of a rare manifestation of tophaceous gout: miliary gout. Int J Rheum Dis 2024;27:e14763.
  • Nieradko-Iwanicka B. The role of alcohol consumption in pathogenesis of gout. Crit Rev Food Sci Nut 2022;62:7129–37.
  • Ma L, Sun R, Jia Z, Zou Y, Xin Y, Cheng X, et al. Clinical characteristics associated with subcutaneous tophi formation in Chinese gout patients: a retrospective study. Clin Rheumatol 2018;37:1359–65.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.